Log In Get Started
Press Releases April 29, 2026 07:21 PM

Methanex Corporation – Notice of Cash Dividend

Methanex Corporation Declares Quarterly Cash Dividend of $0.185 per Share

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
MEOH

Methanex Corporation, the world's largest methanol supplier, announced a quarterly cash dividend of US$0.185 per share payable on June 30, 2026. The dividend applies to shareholders of record on June 16, 2026. The company is listed on both the Toronto Stock Exchange (MX) and Nasdaq (MEOH).

Methanex Corporation – Notice of Cash Dividend
MEOH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Declared a quarterly cash dividend of US$0.185 per share.
  • Dividend payment date set for June 30, 2026 with record date June 16, 2026.
  • Methanex is the world's largest supplier of methanol and is publicly traded on TSX and Nasdaq.

VANCOUVER, British Columbia, April 29, 2026 (GLOBE NEWSWIRE) -- Methanex Corporation (the “Company” or “Methanex”) (TSX:MX) (Nasdaq:MEOH) announced today that its Board of Directors has declared a quarterly dividend of US$0.185 per share. The dividend will be payable on June 30, 2026, to holders of common shares of record on June 16, 2026.

Methanex is a Vancouver-based, publicly traded company and is the world's largest supplier of methanol globally. Methanex shares are listed for trading on the Toronto Stock Exchange in Canada under the trading symbol "MX" and on the Nasdaq Global Select Market in the United States under the trading symbol "MEOH". Methanex can be visited online at www.methanex.com.

Inquiries
Robert Winslow
Investor Relations
Methanex Corporation
604-661-2600 or Toll Free: 1-800-661-8851
www.methanex.com


Risks

  • Dividend payments depend on company earnings and cash flow; economic downturns or methanol price volatility could impact future dividends.
  • Global demand for methanol is subject to economic cycles and energy market fluctuations, affecting company revenue.
  • Operating risks include supply chain disruptions and geopolitical factors impacting global methanol markets.

More from Press Releases

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026